151 related articles for article (PubMed ID: 36864663)
1. Expanding the CRISPR toolbox for Chinese hamster ovary cells with comprehensive tools for Mad7 genome editing.
Rojek JB; Basavaraju Y; Nallapareddy S; Bulté DB; Baumgartner R; Schoffelen S; Grav LM; Goletz S; Pedersen LE
Biotechnol Bioeng; 2023 Jun; 120(6):1478-1491. PubMed ID: 36864663
[TBL] [Abstract][Full Text] [Related]
2. The CRISPR-Cas12a Platform for Accurate Genome Editing, Gene Disruption, and Efficient Transgene Integration in Human Immune Cells.
Mohr M; Damas N; Gudmand-Høyer J; Zeeberg K; Jedrzejczyk D; Vlassis A; Morera-Gómez M; Pereira-Schoning S; Puš U; Oliver-Almirall A; Lyholm Jensen T; Baumgartner R; Tate Weinert B; Gill RT; Warnecke T
ACS Synth Biol; 2023 Feb; 12(2):375-389. PubMed ID: 36750230
[TBL] [Abstract][Full Text] [Related]
3. ErCas12a CRISPR-MAD7 for Model Generation in Human Cells, Mice, and Rats.
Liu Z; Schiel JA; Maksimova E; Strezoska Ž; Zhao G; Anderson EM; Wu Y; Warren J; Bartels A; van Brabant Smith A; Lowe CE; Forbes KP
CRISPR J; 2020 Apr; 3(2):97-108. PubMed ID: 32315227
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas12a-mediated CHO genome engineering can be effectively integrated at multiple stages of the cell line generation process for bioproduction.
Schweickert PG; Wang N; Sandefur SL; Lloyd ME; Konieczny SF; Frye CC; Cheng Z
Biotechnol J; 2021 Apr; 16(4):e2000308. PubMed ID: 33369118
[TBL] [Abstract][Full Text] [Related]
5. Genome editing in plants with MAD7 nuclease.
Lin Q; Zhu Z; Liu G; Sun C; Lin D; Xue C; Li S; Zhang D; Gao C; Wang Y; Qiu JL
J Genet Genomics; 2021 Jun; 48(6):444-451. PubMed ID: 34120856
[TBL] [Abstract][Full Text] [Related]
6. Accelerating genome editing in CHO cells using CRISPR Cas9 and CRISPy, a web-based target finding tool.
Ronda C; Pedersen LE; Hansen HG; Kallehauge TB; Betenbaugh MJ; Nielsen AT; Kildegaard HF
Biotechnol Bioeng; 2014 Aug; 111(8):1604-16. PubMed ID: 24827782
[TBL] [Abstract][Full Text] [Related]
7. Application of CRISPR/Cas9 Genome Editing to Improve Recombinant Protein Production in CHO Cells.
Grav LM; la Cour Karottki KJ; Lee JS; Kildegaard HF
Methods Mol Biol; 2017; 1603():101-118. PubMed ID: 28493126
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9-mediated genome engineering of CHO cell factories: Application and perspectives.
Lee JS; Grav LM; Lewis NE; Faustrup Kildegaard H
Biotechnol J; 2015 Jul; 10(7):979-94. PubMed ID: 26058577
[TBL] [Abstract][Full Text] [Related]
9. Expanding and understanding the CRISPR toolbox for Bacillus subtilis with MAD7 and dMAD7.
Price MA; Cruz R; Bryson J; Escalettes F; Rosser SJ
Biotechnol Bioeng; 2020 Jun; 117(6):1805-1816. PubMed ID: 32077487
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9 as a Genome Editing Tool for Targeted Gene Integration in CHO Cells.
Sergeeva D; Camacho-Zaragoza JM; Lee JS; Kildegaard HF
Methods Mol Biol; 2019; 1961():213-232. PubMed ID: 30912048
[TBL] [Abstract][Full Text] [Related]
11. Expanding the genome editing toolbox of Saccharomyces cerevisiae with the endonuclease ErCas12a.
Bennis NX; Anderson JP; Kok SMC; Daran JG
FEMS Yeast Res; 2023 Jan; 23():. PubMed ID: 37791490
[TBL] [Abstract][Full Text] [Related]
12. Comparison of CRISPR-MAD7 and CRISPR-Cas9 for Gene Disruptions in
Smirnov K; Weiss F; Hatzl AM; Rieder L; Olesen K; Jensen S; Glieder A
J Fungi (Basel); 2024 Mar; 10(3):. PubMed ID: 38535206
[TBL] [Abstract][Full Text] [Related]
13. Optimizing ErCas12a for efficient gene editing in Arabidopsis thaliana.
Pietralla J; Capdeville N; Schindele P; Puchta H
Plant Biotechnol J; 2024 Feb; 22(2):401-412. PubMed ID: 37864303
[TBL] [Abstract][Full Text] [Related]
14. One-step generation of triple knockout CHO cell lines using CRISPR/Cas9 and fluorescent enrichment.
Grav LM; Lee JS; Gerling S; Kallehauge TB; Hansen AH; Kol S; Lee GM; Pedersen LE; Kildegaard HF
Biotechnol J; 2015 Sep; 10(9):1446-56. PubMed ID: 25864574
[TBL] [Abstract][Full Text] [Related]
15. CRISPeering: Bioengineering the Host Cells through CRISPRCas9 Genome Editing System as the Next-generation of Cell Factories.
Morowvat MH
Recent Pat Biotechnol; 2021 Oct; 15(2):137-147. PubMed ID: 33874877
[TBL] [Abstract][Full Text] [Related]
16. De novo assembly and annotation of the CHOZN® GS
Kretzmer C; Narasimhan RL; Lal RD; Balassi V; Ravellette J; Kotekar Manjunath AK; Koshy JJ; Viano M; Torre S; Zanda VM; Kumravat M; Saldanha KMR; Chandranpillai H; Nihad I; Zhong F; Sun Y; Gustin J; Borgschulte T; Liu J; Razafsky D
Biotechnol Bioeng; 2022 Dec; 119(12):3632-3646. PubMed ID: 36073082
[TBL] [Abstract][Full Text] [Related]
17. A Site-Specific Integration Reporter System That Enables Rapid Evaluation of CRISPR/Cas9-Mediated Genome Editing Strategies in CHO Cells.
Hamaker NK; Lee KH
Biotechnol J; 2020 Aug; 15(8):e2000057. PubMed ID: 32500600
[TBL] [Abstract][Full Text] [Related]
18. CRISPR Technologies in Chinese Hamster Ovary Cell Line Engineering.
Glinšek K; Bozovičar K; Bratkovič T
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175850
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-interceded CHO cell line development approaches.
Amiri S; Adibzadeh S; Ghanbari S; Rahmani B; Kheirandish MH; Farokhi-Fard A; Dastjerdeh MS; Davami F
Biotechnol Bioeng; 2023 Apr; 120(4):865-902. PubMed ID: 36597180
[TBL] [Abstract][Full Text] [Related]
20. A ribonucleoprotein-based decaplex CRISPR/Cas9 knockout strategy for CHO host engineering.
Carver J; Kern M; Ko P; Greenwood-Goodwin M; Yu XC; Duan D; Tang D; Misaghi S; Auslaender S; Haley B; Yuk IH; Shen A
Biotechnol Prog; 2022 Jan; 38(1):e3212. PubMed ID: 34538022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
